Literature DB >> 21667463

Prevention of hyperopic surprise after LASIK in patients with refractive multifocal intraocular lenses.

César Albarrán-Diego1, Gonzalo Muñoz, Teresa Ferrer-Blasco, Santiago García-Lázaro.   

Abstract

PURPOSE: Three cases of patients who developed a similar hyperopic defect in refraction following laser in situ keratomileusis (LASIK) after multifocal intraocular lens (IOL) implantation are described.
METHODS: Ophthalmologic evaluation including refractive status, corrected and uncorrected visual acuity (both at far and near), and corneal topography in patients presenting similar hyperopic refractive surprise in one eye as a result of LASIK refinement of residual ametropia after refractive multifocal IOL implantation.
RESULTS: Laser in situ keratomileusis enhancement for residual ametropia of -1.00 to -1.50 D in patients with a prior implantation of refractive multifocal IOL resulted in a refractive surprise of +2.25 to +2.50 D. After excluding other possible sources of error, an explanation for such a refractive surprise is suggested, and a simple method for avoiding this error is presented.
CONCLUSIONS: Proper knowledge of the defocus curve and the use of a systematic method for determining subjective refraction in patients implanted with refractive multifocal IOLs will reduce the possibility of refractive surprise after LASIK enhancement in a bioptics procedure.

Entities:  

Mesh:

Year:  2011        PMID: 21667463     DOI: 10.5301/ejo.5000005

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  2 in total

1.  Validity of automated refraction after segmented refractive multifocal intraocular lens implantation.

Authors:  César Albarrán-Diego; Gonzalo Muñoz; Stephanie Rohrweck; Santiago García-Lázaro; José Ricardo Albero
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

2.  Outcomes of excimer laser enhancements in pseudophakic patients with multifocal intraocular lens.

Authors:  Steven C Schallhorn; Jan A Venter; David Teenan; Julie M Schallhorn; Keith A Hettinger; Stephen J Hannan; Martina Pelouskova
Journal:  Clin Ophthalmol       Date:  2016-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.